Psoriasis of the face and flexures

References

• Spuls Ph I. Clinical evidence for the treatment of moderate to severe psoriasis [Thesis]. Academic Medical Centre, Amsterdam 2002
   Google Scholar
• Krueger G., Koo J., Lebwohl M., Menter A., Stern R. S., Rolstad T. The impact on quality of life: results of a 1998 National Psoriasis Foundation patient‐membership survey. Arch Dermatol 2001; 137: 280–4
   PubMed Web of Science ®Google Scholar
• Fauéré S., Adjadj L., Pawin H. How patients experience psoriasis: Results from a European survey. J Eur Acad Dermatol Venereol 2005; 19((suppl 3))2–6
   PubMedGoogle Scholar
• Dubertret L., Mrowietz U., Ranki A., van de Kerkhof P. C. M., Chimenti S., Lotti T., et al. On behalf of the EUROPSO patient survey. European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729–36
   PubMed Web of Science ®Google Scholar
• Van de Kerkhof P. C. M., de Hoop D., de Korte J., Cobelens S. A., Kuipers M. V. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000; 200: 292–9
   PubMed Web of Science ®Google Scholar
• Farber E. M., Bright R. D., Nall M. L. Psoriasis: A questionnaire survey of 2,144 patients. Arch Dermatol 1968; 98: 248–59
   PubMedGoogle Scholar
• Farber E. M., Nall M. L. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148: 1–18
   PubMedGoogle Scholar
• Wang G., Li C., Gao T., Liu Y. Clinical analysis of 48 cases of inverse psoriasis: A hospital based study. Eur J Dermatol 2005; 15: 176–8
   PubMedGoogle Scholar
• Nanda A., Kaut S., Kaur I., Kumar B. Childhood psoriasis: An epidemiological survey of 112 patients. Pediatr Dermatol 1990; 7: 19–21
   PubMed Web of Science ®Google Scholar
• Puissant A. Psoriasis in children under the age of ten: A study of 100 observations. Gazz Sanit 1970; 19: 191–8
   Google Scholar
• Nyfors A., Lemholt K. Psoriasis in children: A short review and a survey of 245 patients. Br J Dermatol 1975; 92: 437–48
   PubMedGoogle Scholar
• Yosipovitch G., Tang M. B. Y. Practical management of psoriasis in the elderly: Epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging 2002; 19: 847–63
   PubMed Web of Science ®Google Scholar
• Park J. Y., Kim J. H., Choe Y. B. Facial psoriasis: Comparison of patients with and without facial involvement. J Am Acad Dermatol 2004; 50: 582–4
   PubMedGoogle Scholar
• Bernhard J. D., Person J. R. Facial and eyelid psoriasis after cyclosporin withdrawal. Clin Exp Dermatol 1991; 16: 401 [Letter]
   Google Scholar
• Farber E. M. Ear psoriasis. Cutis 1992; 50: 105–7
   PubMedGoogle Scholar
• Erbagci I., Erbagci Z., Gungor K., Bekir N. Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Med Okayama 2003; 57: 299–303
   PubMed Web of Science ®Google Scholar
• Karabulut A. A., Yalvac I. S., Vahaboglu H., Nurozler A. B., Duman S. Conjunctival impression cytology and tear film changes in patients with psoriasis. Cornea 1999; 18: 544–8
   PubMed Web of Science ®Google Scholar
• Guin J. Eyelid dermatitis: Experience in 203 cases. J Am Acad Dermatol 2002; 47: 755–65
   PubMed Web of Science ®Google Scholar
• Rosenberg E. W., Noah P. W., Skinner R. B., Vander Zwaag R., West S. K., Browder J. F. Microbial association of 167 patients with psoriasis. Acta Derm Venereol 1989; 69: 72–5
   Google Scholar
• Flytstroem I., Bergbrant I. M., Braared J., Brandberg L. L. Microorganismes in intertriginous psoriasis: No evidence of candida. Acta Derm Venerol 2003; 83: 121–3
   PubMedGoogle Scholar
• Peramiquel L., Puig L., Dalmau J., Ricart E., Roe E., Alomar A. Onset of flexural psoriasis during infliximab treatment for Crohn's disease. Clin Exp Dermatol 2005; 30: 713–14
   PubMedGoogle Scholar
• Vissers W. H. P. M., Roelofzen J., de Jong E. M., van erp P. E., van de kerkhof P. C. M. Flexural versus plaque lesions in psoriasis: An immunohistochemical differentiation. Eur J Dermatol 2005; 15: 13–17
   PubMedGoogle Scholar
• Minsue Chen T., Cockerell C. J. Cutaneous manifestations of HIV infections and HIV‐related disorders. Dermatology, J. L Bolognia, J. L Jorizzo, R. P Rapini. Mosby, London 2003; 1199–216
   Google Scholar
• Verhagen A. R., van der Wiel A. G., Wuite G. G. A typical psoriasis of the face and hands after psoralen plus UV‐A treatment. Br J Dermatol 1984; 111: 615–18
   PubMedGoogle Scholar
• Tegner E. Observations on PUVA treatment of psoriasis and on 5‐s‐cysteinyldopa after exposure to UV light. Acta Derm Venereol 1983; 107: 1–68
   Google Scholar
• Tegner E. Seborrhoic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol 1983; 63: 335–9
   PubMed Web of Science ®Google Scholar
• Lane C. G., Craford G. M. Psoriasis: A statistical study of 231 cases. Arch Dermatol 1937; 35: 1051–61
   Google Scholar
• Braun‐Falco O., Burg G., Farber E. M. Psoriasis: Eine Fragebogenstudie bei 536 Patienten. Munch Med Wochenschr 1972; 114: 1105–10
   PubMedGoogle Scholar
• Ros A. M., Eklund G. Photosensitive psoriasis: an epidemiologic study. J Am Acad Dermatol 1987; 17: 752–8
   PubMedGoogle Scholar
• Szabo E., Horkay I. Untersuchungen über die Lichtreaktionen bei Psoriasis‐Patienten. Z Haut Geschlechtskr 1965; 39: 425–9
   PubMedGoogle Scholar
• Ros A. M., Wennersten G. Photosensitive psoriasis –clinical findings and phototest results. Photodermatol 1986; 3: 317–26
   PubMedGoogle Scholar
• Kudoh K., Obata M., Torihuki W., Tagami H. Photosensitive psoriasis provoked by a suberythematous dose of ultraviolet B light. Dermatologica 1988; 176: 138–42
   PubMedGoogle Scholar
• Millns J. L., McDuffie F. C., Muller S. A., Jordan R. E. Development of photosensitivity and a systemic lupus erythematosus‐like syndrome in a patient with psoriasis. Arch Dermatol 1978; 114: 1177–81
   PubMedGoogle Scholar
• Sahoo B., Kumar B. The coexistence of photosensitive psoriasis with chronic actinic dermatitis. Dermatology 2002; 204: 77–9
   PubMedGoogle Scholar
• Thaci D., Paetzold S., Kaufmann R. Treatment of intertriginous and genito‐anal psoriasis. Aktuell Dermatol 2003; 29: 505–8
   Google Scholar
• Leigheb G., Gallus D., Spano G. Treatment with psoriasis with an antiseptic combination, in a double‐blind comparison versus eosin. G Ital Dermatol Venereol 2000; 135: 107–14
   Google Scholar
• Faergemann J. Treatment of sebopsoriasis with itraconazole. Mykoses 1985; 28: 612–18
   PubMedGoogle Scholar
• Doering H. F. Therapy and etiology of sebopsoriasis. Z Hautkr 1985; 6: 1940–50
   Google Scholar
• Gupta A. K., Bluhm R. Itraconazole for seborrhoic dermatitis. Skin Therapy Lett 2002; 7((suppl 1))4–8
   PubMedGoogle Scholar
• Heller G. Niedrig konzentriertes Dithranol bie Psoriasis des Gesichtes. Dermatol Monatsschr 1989; 175: 35–9
   PubMedGoogle Scholar
• Lebwohl M. G., Tan M. H., Meador S. L., Singer G. Limited application of fluticasone propionate ointment 0,005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol 2001; 44: 77–82
   PubMed Web of Science ®Google Scholar
• Nakayama J. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1α‐24(R)‐dihydroxycholecalciferol (tacalcitol) cream. Eur J Dermatol 2000; 10: 528–32
   PubMed Web of Science ®Google Scholar
• Tadaki T., Kato T., Tagami H. Topical active vitamin D‐3 analogue, 1,24‐dihydroxycholecalciferol, an effective new treatment for facial seborrhoeic dermatitis. J Dermatolog Treat 1996; 7: 139–40
   Web of Science ®Google Scholar
• Aste N. Tacalcitol ointment in the treatment of psoriasis. G Ital Dermatol Venereol 2004; 139: 81–4
   Google Scholar
• Langer A., Stapor V., Verjans H., Elzerman J. Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis. J Dermatolog Treat 1996; 7((suppl l))S15–S18
   Google Scholar
• Duweb G. A., Eldebani S., Alhaddar J. Calcipotriol cream in the treatment of flexural psoriasis. Int J Tissue React 2003; 25: 127–30
   PubMedGoogle Scholar
• Kienbaum S., Lehmann P., Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol 1996; 135: 647–50
   PubMed Web of Science ®Google Scholar
• Ortonne J. P., Humbert P., Nicolas J. F., Tsankov N., Tonev S. D., Janin A., et al. Intraindividual comparison of the cutaneous safety and efficacy of calcitriol 3 mcg g−1 ointment and calcipotriol 50 mcg g−1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauriculair or flexural areas. Br J Dermatol 2003; 148: 326–33
   PubMed Web of Science ®Google Scholar
• Lebwohl M., Freeman A. K., Chapman M. S., Feldman S. R., Hartle J. E., Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004; 51: 723–30
   PubMed Web of Science ®Google Scholar
• Lebwohl M., Freeman A., Chapman M. S., Feldman S., Hartle J., Henning A. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol 2005; 141: 1154 [Letter]
   Google Scholar
• Gribetz C., Ling M., Lebwohl M., Pariser D., Draelos Z., Gottlieb A. B., et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double‐blind, randomized study. J Am Acad Dermatol 2004; 51: 731–8
   PubMed Web of Science ®Google Scholar
• Freeman A. K., Linowski G. J., Brady C., Lind L., Vanveldhuisen P., Singer G., et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003; 48: 564–8
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Nishioka K. Topical tacrolimus: An effective therapy for facial psoriasis. Eur J Dermatol 2003; 13: 471–3
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Nishioka K. Topical tacrolimus is effective for facial lesions of psoriasis. Acta Dermatol Venereol 2000; 80: 451 [Letter]
   Google Scholar
• Kroft E. M. B., Erceg A., Maimets K., Vissers W., van der Valk P. G., van de Kerkhof P. C. M. Tacrolimus ointment for the treatment of severe facial plaque psoriasis. J Eur Acad Dermatol Venereol 2005; 19: 249–51
   PubMedGoogle Scholar
• Clayton T. H., Harrison P. V., Nicholls R., Delap M. Topical tacrolimus for facial psoriasis. Br J Dermatol 2003; 149: 419–20
   PubMedGoogle Scholar
• Steele J. A., Choi C., Kwong P. C. Topical tacrolimus in the treatment of inverse psoriasis. J Am Acad Dermatol 2005; 53: 713–16
   PubMed Web of Science ®Google Scholar
• Kleyn C. E., Woodcock D., Sharpe G. R. The efficacy of 0.1% tacrolimus ointment compared with clobetasonebutyrate 0.05% ointment in patients with facial flexural or genital psoriasis. Br J Dermatol 2005; 153((suppl 1))33 [Abstract]
   Google Scholar
• Rallis E., Nasiopoulou A., Kouskoukis C., Roussaki‐Schulze A., Koumantaki E., Karpouzis A., et al. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%. Drugs Exp Clin Res 2005; 31: 141–5
   PubMedGoogle Scholar
• Amichai B. Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream. J Eur Acad Dermatol Venereol 2004; 18: 742–3
   PubMed Web of Science ®Google Scholar
• Gollnick H. P. M., Finzi A. F., Marks R., Barker J. N., Jansen C., Revuz J., et al. Optimizing the use of tazarotene in clinical practice: Consensus statement from the European Advisory Panel for tazarotene (Zorac™). Dermatology 1999; 199: 40–6
   PubMed Web of Science ®Google Scholar